97
Views
1
CrossRef citations to date
0
Altmetric
FLOW INJECTION ANALYSIS

Study of On-Line Fluorimetric Determination of Oxazepam. Application to the Screening of 1,4-Benzodiazepines Giving Oxazepam as Metabolite in Urine

, , &
Pages 1826-1835 | Received 16 May 2012, Accepted 11 Jul 2012, Published online: 11 Jul 2013

REFERENCES

  • Berrueta , L. A. , B. Gallo , and F. Vicente . 1993 . Analysis of oxazepam in urine using solid-phase extraction and high-performance liquid chromatography with fluorescence detection by post-column derivatization . J. Chromatogr. B. 616 : 344 – 348 .
  • Borrey , D. , E. Meyer , L. Ducheteau , W. Lambert , C. Van Peteghem , and A. De Leenheer . 2002 . Enzymatic Hydrolysis Improves the Sensitivity of Emit Screening for Urinary Benzodiazepines . Clin. Chem. 48 : 2047 – 2049 .
  • De Giovanni , N. , and M. Chiarotti . 1988 . Analysis of benzodiazepines: II. High-performance liquid chromatography-fluorescence detection after molecular rearrangement to acridanones . J. Chromatogr. B. 428 : 321 – 329 .
  • Dolejšová , J. , P. Solich , C. K. Polydorou , M. A. Koupparis , and C. E. Efstathiou . 1999 . Flow-injection fluorimetric determination of 1,4-benzodiazepines in pharmaceutical formulations after acid hydrolysis . J. Pharm. Biomed. Anal. 20 : 357 – 362 .
  • Gambart , D. , S. Cárdenas , M. Gallego , and M. Valcárcel . 1998 . An automated screening system for benzodiazepines in human urine . Anal. Chim. Acta. 366 : 93 – 102 .
  • Gifford , L. A. , J. N. Miller , J. W. Bridges , and D. T. Burns . 1977 . Luminescence characteristics of several classes of drugs affecting the central nervous system . Talanta 24 : 273 – 275 .
  • Gil Tejedor , A. M. , P. Fernández Hernando , and J. S. Durand Alegría . 2007 . A rapid fluorimetric screening method for the 1,4-benzodiazepines: determination of their metabolite oxazepam in urine . Anal. Chim. Acta. 591 : 112 – 215 .
  • Idris , A. M. 2010a . An overview of the generations and recent versions of flow injection techniques . Crit. Rev. Anal. Chem. 40 : 150 – 158 .
  • Idris , A. M. 2010b . Flow injection, overlooked techniques in forensic analysis . Crit. Rev. Anal. Chem. 40 : 218 – 225 .
  • Kirschbaum , K. M. , F. Musshoff , A. Wilbert , J. Röhrich , and B. Madea . 2011 . Direct ELISA kits as a sensitive and selective screening method for abstinence control in urine . Forensic Sci. Int. 207 : 66 – 69 .
  • Lai , C. , T. Lee , K. Au , and A. Y. Chan . 1997 . Uniform solid-phase extraction procedure for toxicological drug screening in serum and urine by HPLC with photodiode-array detection . Clin. Chem. 43 : 312 – 325 .
  • Lu , N. T. , and B. G. Taylor . 2006. Drug screening and confirmation by GC–MS: Comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories. Forensic Sci. Int. 157: 106–116.
  • Mandrioli , R. , L. Mercolini , and M. A. Raggi . 2008 . Benzodiazepine metabolism: an analytical perspective . Curr. Drug Metab. 9 : 827 – 844 .
  • Melchert , W. R. , B. F. Reis , and F. R. P. Rocha . 2012 . Green chemistry and the evolution of flow analysis. A review . Anal. Chim. Acta. 714 : 8 – 19 .
  • Miller , J. C. , and J. N. Miller . 1993 . Statistics for Analytical Chemistry . Wilmington , Delaware : Addison-Wesley Iberoamericana .
  • Pelander , A. , I. Ojanpera , S. Laks , I. Rasanen , and E. Vuori . 2003 . Toxicological Screening with Formula-Based Metabolite Identification by Liquid Chromatography/Time-of-Flight Mass Spectrometry . Anal. Chem. 75 : 5710 – 5718 .
  • Phillips , J. E. , S. Bogema , P. Fu , W. Furmaga , A. H. B. Wu , V. Zic , and C. Hammett-Stabler . 2003 . Signify® ER Drug Screen Test evaluation: comparison to Triage® Drug of Abuse Panel plus tricyclic antidepressants . Clin. Chim. Acta. 328 : 31 – 38 .
  • Roy-Byrne , P. P. , and D. S. Cowley . 1991 . Benzodiazepines in clinical practice: Risks and benefits . Washington , USA : American Psychiatric Press .
  • Ruzicka , J. , and E. H Hansen . 2000 . Flow inje ction analysis: From beaker to microfluidics . Anal. Chem. 72 : 212A – 217A .
  • Schütz , H. 1989 . Benzodiazepines II: a handbook. Basic data, analytical methods, pharmacokinetics and comprehensive literature . New York , New York : Springer .
  • Siek , T. J. , C. W. Stradling , M. W. McCain , and T. C. Mehary . 1997 . Computer-aided identifications of thin-layer chromatographic patterns in broad-spectrum drug screening . Clin. Chem. 43 : 619 – 626 .
  • Smith-Kielland , A. , B. Skuterud , K. M. Olsen , and J.Mørland. 2001 . Urinary excretion of diazepam metabolites in healthy volunteers and drug users. Scand . J. Clin. Lab. Invest. 61 : 237 – 246 .
  • Sweetman , S. C. 2009 . Martindale: The complete drug reference . London : Pharmaceutical Press .
  • Szekelhidi , L. , A. Lapat , and I. Hornyák . 1989 . Spectrofluorimetric determination of 2-amino-5-chlorobenzophenone impurity in chlordiazepoxide hydrochloride . Anal. Chim. Acta. 227 : 309 – 310 .
  • Valentour , J. C. , J. R. Monforte , B. Lorenzo , and I. Sunshine . 1975 . Fluorometric screening method for detecting benzodiazepines in blood and urine . Clin. Chem. 21 : 1976 – 1979 .
  • Violon , C. , L. Pessemier , and A. Vercruysse . 1982 . High-performance liquid chromatography of benzophenone derivatives for the determination of benzodiazepines in clinical emergencies . J. Chromatogr. A. 236 : 157 – 168 .
  • Walash , M. I. , F. Belal , M. E. Metwally , and M. M. Hefnawy . 1994 . A selective fluorimetric method for the determination of some 1,4-benzodiazepine drugs containing a hydroxyl group at C-3 . J. Pharm. Biomed. Anal. 12 : 1417 – 1423 .
  • Way , B. A. , K. G. Walton , J. W. Koenig , B. J. Eveland , and M. G. Scott . 1998 . Comparison between the CEDIA and EMIT II immunoassays for the determination of benzodiazepines . Clin. Chim. Acta 271 : 1 – 9 .
  • World Health Organization . 2009 . 17th Expert Committee on the Selection and Use of Essential Medicines Proposal. Geneva, Swiss: WHO. Available from http://www.who.int/entity/selection_medicines/committees/expert/17/application/Section24_GAD.pdf (last accessed on July 2012).
  • World Health Organization . 2011 . Model List of Essential Medicines . Geneva , Swiss : WHO . Available from http://whqlibdoc.who.int/hq/2011/a95053_eng.pdf (last accessed on July 2012) .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.